Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum

INTRODUCTION: Amyloid beta (Aβ), tau, and neurodegeneration jointly with the Alzheimer's disease (AD) risk factors affect the severity of clinical symptoms and disease progression. METHODS: Within 248 Aβ‐positive elderly with and without cognitive impairment and dementia, partial least squares...

Descripción completa

Detalles Bibliográficos
Autores principales: Tosun, Duygu, Demir, Zeynep, Veitch, Dallas P., Weintraub, Daniel, Aisen, Paul, Jack, Clifford R., Jagust, William J., Petersen, Ronald C., Saykin, Andrew J., Shaw, Leslie M., Trojanowski, John Q., Weiner, Michael W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Featured Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014819/
https://www.ncbi.nlm.nih.gov/pubmed/34647694
http://dx.doi.org/10.1002/alz.12480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014819/
https://www.ncbi.nlm.nih.gov/pubmed/34647694
http://dx.doi.org/10.1002/alz.12480

Ejemplares similares